Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit. (2024). Biomedical Research and Therapy, 11(4), 6305-6325. https://doi.org/10.15419/bmrat.v11i4.877